Journal of Pharmacovigilance & Drug Safety

Ma??l Sha??r (Barley Water): Traditional Unani Perspectives Integrated with Phytochemistry and Modern Clinical Insights

Samreen Farha — 2025-12-13

Emerging Frontiers in Pharmacovigilance: Harnessing Digital Innovations and AI for Enhanced Drug Safety Monitoring in Modern and Traditional Medicine

Arshad Hasan — 2025-12-13

Pharmacovigilance, the science of detecting, assessing, understanding, and preventing adverse drug reactions (ADRs), has evolved significantly since its formal inception following the thalidomide tragedy. This review examines the historical progression of pharmacovigilance, highlighting the limitations of traditional methods and the paradigm shifts driven by technological advancements. It explores the transformative role of digital technologies, including big data analytics, social media integration, and mobile health (mHealth) applications, in enhancing drug safety monitoring. The application of artificial intelligence (AI) and machine learning (ML) in signal detection, natural language processing (NLP), and the development of AI-enabled pharmacovigilance platforms are critically assessed, emphasizing their potential to improve the speed and accuracy of ADR identification. Furthermore, this review addresses the unique challenges and strategies for pharmacovigilance in traditional medicine, where safety profiles are often underreported. It investigates the importance of integrating digital and AI-driven tools to monitor traditional remedies, including the use of blockchain for supply chain transparency. Finally, the review discusses current regulatory frameworks and the importance of global collaboration in establishing standardized pharmacovigilance practices. By synthesizing historical perspectives with emerging digital innovations, this paper underscores the importance of a comprehensive, inclusive approach to drug safety monitoring, aimed at optimizing patient outcomes and reinforcing public trust in both modern and traditional medicinal products.

Report on 5th National Pharmacovigilance Week celebration by ADR Monitoring Centre, JNMC, AMU, Aligarh

Syed Ziaur Rahman — 2025-12-24

Every year, #MedSafetyWeek brings together people from around the world to focus on one shared message: medicines are most effective when they are also safe1. This simple idea carries great importance, especially in countries like India where the use of medicines is widespread across diverse healthcare settings. This year, Aligarh, a small city in the state of Uttar Pradesh, contributed thoughtfully to the global conversation. A special programme was organised by the Adverse Drug Reaction Monitoring Centre (AMC) at Ibn Sina Academy and Jawaharlal Nehru Medical College (JNMC), in collaboration with the Society of Pharmacovigilance, India (SoPI). The event took place under the guidance of the Pharmacovigilance Programme of India (PvPI), coordinated by the Indian Pharmacopoeia Commission (IPC), which also serves as a National Coordinating Centre for Pharmacovigilance Programme of India (PvPI).